San Diego Budget Analyst Warns of Long-Term Deficits as Local Biotech Halozyme Faces Patent Rulings

Fiscal Watchdog Projects Substantial Shortfalls Between FY 2029 and 2032

SAN DIEGO, California — During a San Diego City Council budget committee hearing, Independent Budget Analyst Charles Modica pushed back against Mayor Todd Gloria's contention that the city has resolved its structural budget deficit. Modica and several councilmembers warned that current multi-year projections still show steep revenue gaps emerging between fiscal years 2029 and 2032.

Halozyme Patent Litigation and Cutwater Miramar Growth Spotlight Local Firms

In San Diego corporate developments, biotechnology firm Halozyme Therapeutics drew investor focus following updates in European patent and injunction proceedings tied to its drug-delivery technology used in Keytruda SC. Meanwhile, Anheuser-Busch highlighted Miramar-based Cutwater Spirits as a major driver of its national canned-cocktail expansion.